Skip to main content
. Author manuscript; available in PMC: 2020 Nov 16.
Published in final edited form as: Breast Cancer Res Treat. 2013 Nov 26;143(1):11–18. doi: 10.1007/s10549-013-2758-9

Table 3.

Tests of CD44 expression as a predictor of PFS and OS after grouping patients by tumor size and nodal status

Characteristic Median PFS (years) p Median OS (years) p
Tumor size ≤2 cm 0.019 0.133
 CD44 negative (n = 8) 11.0 9.4
 CD44 positive (n = 10) Not reached Not reached
Tumor size >2 cm 0.800 0.346
 CD44 negative (n = 21) 3.9 7.5
 CD44 positive (n = 12) 5.3 8.4
Node negative 0.997 0.776
 CD44 negative (n = 11) 17.1 14.4
 CD44 positive (n = 11) 17.9 22.2
Node positive 0.069 0.021
 CD44 negative (n = 18) 3.4 6.3
 CD44 positive (n = 11) 10.3 15.6

Median PFS and OS values are Kaplan–Meier estimates. p values obtained using Log Rank test

Bold values indicate a statiscally significant result (i.e., p< 0.05)